Traws Pharma's total assets for Q3 2024 were $8.94M, a decrease of -52.18% from the previous quarter. TRAW total liabilities were $10.97M for the fiscal quarter, a -12.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.